1-20 of 89
Lei Feng
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Six Years Follow up of Ibrutinib Plus Rituximab (IR) Followed By Short Course R-Hyper CVAD/MTX in Patients (age ≤ 65 years) with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-1 Clinical Trial

Preetesh Jain, Hun Ju Lee, Jason Westin, Loretta J. Nastoupil, Luis Fayad, Ranjit Nair, Swami P. Iyer, Rashmi Kanagal-Shamanna, Ahmed Fetooh, Holly A Hill, Chi Young Ok, Wendy Chen, Onyeka Oriabure, Lei Feng, Guilin Tang, Francisco Vega, Maria Badillo, Christopher R. Flowers, Michael L. Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 1688.
https://doi.org/10.1182/blood-2023-181312
Published: 2023
Journal Articles

Phase 1 Dose Escalation Study of Pembrolizumab in Combination with Rituximab and Lenalidomide for Relapsed/Refractory Large B-Cell or Follicular Lymphoma Following Progression after Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy

Dustin McCurry, Jason Westin, Lei Feng, Sairah Ahmed, Ranjit Nair, Raphael Eric Steiner, Lauren Wynn, Jennifer Thomas, Ly Huynh Dsouza, Felipe Samaniego, Sattva S. Neelapu, Loretta J. Nastoupil
Journal: Blood
Blood (2023) 142 (Supplement 1): 4466.
https://doi.org/10.1182/blood-2023-182978
Published: 2023
Journal Articles

Smart Stop: Lenalidomide, Tafasitamab, Rituximab, and Acalabrutinib Alone and with Combination Chemotherapy for the Treatment of Newly Diagnosed Diffuse Large B-Cell Lymphoma

Jason Westin, Raphael E Steiner, Dai Chihara, Sairah Ahmed, Preetesh Jain, Luis Malpica, Swami P. Iyer, Luis Fayad, Ranjit Nair, Loretta J. Nastoupil, Sattva S. Neelapu, Jared Henderson, Maria Alma Rodriguez, F. B. Hagemeister, Francisco Vega, Brittani Pulsifer, Jisha Tom, Isak Durmic, Gita Masand, Lei Feng, Michael R. Green, Christopher R. Flowers, Paolo Strati
Journal: Blood
Blood (2023) 142 (Supplement 1): 856.
https://doi.org/10.1182/blood-2023-180381
Published: 2023
Journal Articles

Outcomes in Patients with Relapsed Refractory T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Treated with CAR-T Cell Therapies or Salvage Chemotherapy - a Single-Institution Experience

Ranjit Nair, Iyanuoluwa Ogundipe, Jillian Gunther, L. Jeffrey Medeiros, Preetesh Jain, Loretta J. Nastoupil, Chelsea Camille Pinnix, Luis Malpica, Sairah Ahmed, Roberto Miranda, Luis Fayad, Raphael E Steiner, Frederick Hagemeister, Hun Ju Lee, Maria Alma Rodriguez, Paolo Strati, Dai Chihara, Michael Wang, Yago Nieto, Jeremy Ramdial, Ajlan Al Zaki, Chijioke Nze, Michael R. Green, Bouthaina S. Dabaja, Jie Xu, Beenu Thakral, Sattva S. Neelapu, Francisco Vega, Christopher R. Flowers, Penny Fang, Jason Westin, Lei Feng, Swami P. Iyer
Journal: Blood
Blood (2023) 142 (Supplement 1): 6327.
https://doi.org/10.1182/blood-2023-191096
Published: 2023
Journal Articles

Phase II Trial of Ibrutinib in Previously Untreated High-Risk Smoldering Mantle Cell Lymphoma

Charles Gaulin, Preetesh Jain, Ranjit Nair, Swami P. Iyer, Hun Ju Lee, Luis Fayad, Lei Feng, Yang Liu, Holly A Hill, Yijing Li, Chi Young Ok, Rashmi Kanagal-Shamanna, Onyeka Oriabure, Wendy Chen, Asiya Siddiqui, Guofan Xu, Anita Deswal, Cezar Iliescu, Maria Badillo, Shaoying Li, Michelle Ky, Michelle Avellaneda, Guilin Tang, Francisco Vega, Christopher R. Flowers, Michael L. Wang
Journal: Blood
Blood (2023) 142 (Supplement 1): 3034.
https://doi.org/10.1182/blood-2023-187903
Published: 2023
Journal Articles

Nivolumab and Ibrutinib for Treatment of Patients with Refractory or Relapsed Central Nervous System Lymphoma

Jason Westin, Ranjit Nair, Luis Fayad, Swami P. Iyer, Luis Malpica, Sattva S. Neelapu, Felipe Samaniego, Raphael Eric Steiner, Paolo Strati, Shivon Mathew, Donna Griffith, Loretta J. Nastoupil, Wirt Montinez, Maria Alma Rodriguez, Frederick Hagemeister, Lei Feng, Francisco Vega, Christopher R. Flowers, Sairah Ahmed
Journal: Blood
Blood (2023) 142 (Supplement 1): 1721.
https://doi.org/10.1182/blood-2023-191123
Published: 2023
Journal Articles

A Phase II Study of Loncastuximab Tesirine As Consolidation Strategy in Patients with LBCL in PR at Day 30 after CAR T-Cell Therapy

Ajlan Al Zaki, Lei Feng, Jason Westin, Ranjit Nair, Luis Fayad, Grace Watson, Sherry Adkins, Elizabeth J. Shpall, Mario L. Marques-Piubelli, Jared Henderson, Loretta J. Nastoupil, Christopher R. Flowers, Sairah Ahmed, Sattva S. Neelapu, Paolo Strati
Journal: Blood
Blood (2023) 142 (Supplement 1): 3098.
https://doi.org/10.1182/blood-2023-179004
Published: 2023
Journal Articles

Acalabrutinib with Rituximab As First-Line Therapy for Older Patients with Mantle Cell Lymphoma - a Phase II Clinical Trial

Preetesh Jain, Chi Young OK, Loretta J. Nastoupil, Jason Westin, Holly A Hill, Ranjit Nair, Swami P. Iyer, Ahmed Fetooh, Hun Ju Lee, Sairah Ahmed, Rashmi Kanagal-Shamanna, Fatima Z Jelloul, Luis Enrique Malpica Castillo, Yang Liu, Yijing Li, Jovanny Vargas, Lei Feng, Maria Badillo, Selvi Thirumurthi, Guofan Xu, Anita Deswal, Cezar Iliescu, Vinh Quang Nguyen, Guilin Tang, Keyur P. Patel, Francisco Vega, L. Jeffrey Medeiros, Michael L. Wang, Christopher R. Flowers
Journal: Blood
Blood (2023) 142 (Supplement 1): 3036.
https://doi.org/10.1182/blood-2023-181216
Published: 2023
Journal Articles

Addition of Acalabrutinib to Lenalidomide and Rituximab Induces High Complete Response Rates in Patients with Previously Untreated Follicular Lymphoma: Results of a Phase II Study

Paolo Strati, Lei Feng, Jason Westin, Ranjit Nair, Luis Fayad, Maria Alma Rodriguez, Dai Chihara, Luis Malpica, Jared Henderson, Mariana Gallardo, Mario L. Marques-Piubelli, Polina Turova, Aleksandr Zaitsev, Iris Wang, Christopher R. Flowers, Loretta J. Nastoupil, Sattva S. Neelapu
Journal: Blood
Blood (2023) 142 (Supplement 1): 983.
https://doi.org/10.1182/blood-2023-180762
Published: 2023
Journal Articles

Updated Results of an Investigator-Initiated Phase II Study of Pembrolizumab and Romidepsin for Patients with Relapsed or Refractory T-Cell Lymphoma (TCL) with Survival Analysis

Owhofasa O. Agbedia, Rishab Prakash, Jie Xu, Melody R. Becnel, Ranjit Nair, Raphael E Steiner, Lei Feng, Hun Ju Lee, Paolo Strati, Sairah Ahmed, Simrit Parmar, Yago Nieto, Chitra Hosing, Jason Westin, Loretta J. Nastoupil, Ann Vo, Felipe Samaniego, Nathan H. Fowler, Neeraj Saini, Issa F. Khouri, Jin S. Im, Luis Fayad, Preetesh Jain, Michael L. Wang, Roberto N. Miranda, Francisco Vega, Jeffrey Medeiros, Yasuhiro Oki, Christopher R. Flowers, Sattva S. Neelapu, Swaminathan P. Iyer
Journal: Blood
Blood (2022) 140 (Supplement 1): 2313–2315.
https://doi.org/10.1182/blood-2022-168983
Published: 2022
Journal Articles

Phase II Study of Pembrolizumab and Fractionated External Beam Radiotherapy in Patients with Relapsed and Refractory Large B-Cell Lymphoma

Chelsea C. Pinnix, Bouthaina S. Dabaja, Jillian R. Gunther, Penny Fang, Susan Wu, Sairah Ahmed, Raphael E Steiner, Ranjit Nair, Paolo Strati, Jason Westin, Luis Fayad, Swami P. Iyer, Maria Alma Rodriguez, Hun Ju Lee, Felipe Samaniego, Dai Chihara, Preetesh Jain, Lei Feng, Christopher R. Flowers, Sattva S. Neelapu, Loretta J. Nastoupil
Journal: Blood
Blood (2022) 140 (Supplement 1): 3741–3743.
https://doi.org/10.1182/blood-2022-168540
Published: 2022
Journal Articles

Cutaneous/ Subcutaneous Involvement - an Immune privileged Site Associated with Poor Outcomes in Systemic Peripheral T/ NK Cell Lymphoma.

Ranjit Nair, Rishab Prakash, Anna Dang, Jillian R. Gunther, Auris Huen, Jie Xu, Luis Enrique Malpica Castillo, Carlos Torres Cabala, Meghan Heberton, Penny Fang, Sairah Ahmed, Roberto N. Miranda, Luis Fayad, Raphael Steiner, Hun Ju Lee, Dai Chihara, Preetesh Jain, Samer A Srour, Jeremy L Ramdial, Yago Nieto, Loretta J. Nastoupil, Chelsea C. Pinnix, Sattva S. Neelapu, Christopher R. Flowers, L. Jeffrey Medeiros, Chitra Hosing, Michael L. Wang, Bouthaina S. Dabaja, Francisco Vega, Lei Feng, Swaminathan Padmanabhan Iyer
Journal: Blood
Blood (2022) 140 (Supplement 1): 12005–12007.
https://doi.org/10.1182/blood-2022-170750
Published: 2022
Journal Articles

Initial Results of a Phase 1 Study of Daratumumab, Ixazomib, and Dexamethasone in Newly Diagnosed and Previously Treated AL Amyloidosis

Hans C. Lee, Gregory P. Kaufman, Lei Feng, Astrid Murga, Ralph J. Johnson, Donna M. Weber, Sheeba K Thomas, Qaiser Bashir, Muzaffar H Qazilbash, Swaminathan P. Iyer, Krina Patel, Melody R. Becnel, Elisabet E. Manasanch, Robert Z. Orlowski
Journal: Blood
Blood (2022) 140 (Supplement 1): 4428–4430.
https://doi.org/10.1182/blood-2022-167555
Published: 2022
Journal Articles

Effect of Delayed Cell Infusion in Patients with Large B-Cell Lymphoma Treated with CAR T-Cell Therapy

Andrew Jallouk, Lei Feng, Mansoor Noorani, Kaberi Das, Raphael E Steiner, Loretta J. Nastoupil, Misha Hawkins, Ranjit Nair, Jason Westin, Luis Fayad, Dai Chihara, Luis Enrique Malpica Castillo, Swaminathan P. Iyer, Sairah Ahmed, Elizabeth J Shpall, Partow Kebriaei, Sattva S. Neelapu, Paolo Strati
Journal: Blood
Blood (2022) 140 (Supplement 1): 10424–10426.
https://doi.org/10.1182/blood-2022-166783
Published: 2022
Journal Articles

Prognostic Significance of Cutaneous Angioimmunoblastic T-Cell Lymphoma: Correlation of Clinical, Histologic and Immunophenotypic Features with Response

Christopher N Nguyen, Rishab Prakash, Madeleine Duvic, Meghan Heberton, Julia Dai, Ranjit Nair, Luis Enrique Malpica Castillo, Carlos Torres Cabala, Lei Feng, Swaminathan Padmanabhan Iyer, Auris Huen
Journal: Blood
Blood (2022) 140 (Supplement 1): 9406–9407.
https://doi.org/10.1182/blood-2022-163810
Published: 2022
Journal Articles

CD19 CAR-T Outcomes in Patients with EBV-Positive DLBCL

Ranjit Nair, Amy Ayers, Loretta J. Nastoupil, Jillian R. Gunther, Luis Fayad, Nathan H. Fowler, Roberto N. Miranda, Fredrick B. Hagemeister, Hun Ju Lee, Maria Alma Rodriguez, Raphael Steiner, Paolo Strati, Yago Nieto, Jeremy L. Ramdial, Dai Chihara, Michael L. Wang, Luis E Malpica Castillo, Neeraj Saini, Preetesh Jain, Chelsea C. Pinnix, Bouthaina S. Dabaja, Michael R Green, Christopher R. Flowers, L. Jeffrey Medeiros, Mario L. Marques-Piubelli, Francisco Vega, Mansoor Noorani, Sairah Ahmed, Jason Westin, Sattva S. Neelapu, Lei Feng, Swaminathan Padmanabhan Iyer
Journal: Blood
Blood (2022) 140 (Supplement 1): 3800–3802.
https://doi.org/10.1182/blood-2022-171120
Published: 2022
Journal Articles

Primary Analysis of a Pilot Study of Prophylactic Anakinra to Mitigate CAR T Cell-Associated Toxicity in Patients with Relapsed or Refractory Large B-Cell Lymphoma

Paolo Strati, Xubin Li, Qing Deng, Lei Feng, Ryan Sun, Andrew Jallouk, Sherry Adkins, Taylor Cain, Swapna Johncy, Raphael E Steiner, Sairah Ahmed, Dai Chihara, Luis Fayad, Swaminathan Padmanabhan Iyer, Sandra B. Horowitz, Rachel Nehlsen, Loretta J. Nastoupil, Ranjit Nair, Ahmed Hassan, Taher Daoud, Misha Hawkins, Felipe Samaniego, Maria Alma Rodriguez, Elizabeth J Shpall, Partow Kebriaei, Christopher R. Flowers, David Hong, Jason Westin, Sattva S. Neelapu, Michael R. Green
Journal: Blood
Blood (2022) 140 (Supplement 1): 7493–7495.
https://doi.org/10.1182/blood-2022-157448
Published: 2022
Journal Articles

Comorbidities Associated with Early Mortality after CD19 CAR-T Cell Therapy

Kevin Tang, Raamis Khwaja, Lei Feng, Paolo Strati, Raphael E. Steiner, Ranjit Nair, Christopher R. Flowers, Neeraj Saini, Jeremy L. Ramdial, Samer A. Srour, Richard E. Champlin, Gabriela Rondon, Janet Torres, Partow Kebriaei, Loretta J. Nastoupil, Haleigh Mistry, Elizabeth J. Shpall, Yago Nieto, Jason Westin, Sattva S. Neelapu, Sairah Ahmed
Journal: Blood
Blood (2022) 140 (Supplement 1): 4684–4685.
https://doi.org/10.1182/blood-2022-166267
Published: 2022
Journal Articles

Axicabtagene Ciloleucel in Relapsed or Refractory Large B-Cell Lymphoma Patients in Complete Metabolic Response at Time of Infusion

Sushanth Gouni, Jason R. Westin, Haleigh Mistry, Raphael Eric Steiner, Jinsu James, Simrit Parmar, Mansoor Noorani, Nathan H. Fowler, Sandra B. Horowitz, Lei Feng, Luis E. Fayad, Swaminathan P Iyer, Michael R Green, Misha Hawkins, Christopher R. Flowers, Sairah Ahmed, Loretta Nastoupil, Sattva S. Neelapu, Yago Nieto, Paolo Strati
Journal: Blood
Blood (2021) 138 (Supplement 1): 1740.
https://doi.org/10.1182/blood-2021-145503
Published: 2021
Journal Articles

Analysis of Factors Associated with Conversion to CR in Patients with Large B-Cell Lymphoma Achieving Day 30 PR after CAR T-Cell Therapy

Ajlan Al Zaki, Jason R. Westin, Grace Watson, Lei Feng, Sairah Ahmed, Haleigh Mistry, Loretta Nastoupil, Misha Hawkins, Ranjit Nair, Swaminathan P Iyer, Hun Lee, Raphael E Steiner, Christopher R. Flowers, Elizabeth J. Shpall, Partow Kebriaei, Sattva S. Neelapu, Paolo Strati
Journal: Blood
Blood (2021) 138 (Supplement 1): 3870.
https://doi.org/10.1182/blood-2021-146023
Published: 2021